Tactile Systems Technology, Inc. (TCMD)
Tactile Systems Technology, Inc. is a medical device company that specializes in developing and manufacturing hydraulic compression devices for the treatment of various chronic and acute medical conditions, particularly lymphedema and venous ulcers. The company's products are designed to improve patient outcomes through non-invasive therapy options, and it primarily serves healthcare providers and institutions.
Company News
The article highlights three small-cap stocks with potential for growth in 2025, focusing on insider and institutional buying amid improving macroeconomic conditions and potential interest rate cuts.
Tactile Medical has announced the commercial availability of its next-generation pneumatic compression device, Nimbl, for the treatment of upper extremity lymphedema. Nimbl is significantly smaller, lighter, and more user-friendly than previous devices, and it has received FDA and CMS approvals.
The global compression therapy market is expected to reach a valuation of USD 6.26 billion by 2031, growing at a CAGR of 5.40% during the forecast period. The market is driven by the increasing cases of accidents and sports injuries, as well as the growing demand for compression garments and pumps.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The medical technology company announced light Q4 revenue and underwhelming forward guidance.